Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
复制标题
DOI:
10.1093/annonc/mdw350
复制
发表时间:
2016-09-01
影响因子:
50.5
通讯作者:
Arnold, D.
中科院分区:
文献类型:
--
作者:
Smyth, E. C.;Verheij, M.;Arnold, D.
Almost one million (951 600) new cases of gastric cancer were diagnosed globally in 2012, resulting in∼ 723 100 deaths [1]. Of these∼ 140 000 cases and∼ 107 000 deaths occurred in Europe [2]. Gastric cancer displays significant global variation in incidence; the highest rates are seen in Eastern Asia, Eastern Europe and South America, with lower rates in North America and Western Europe. A gradual decline in the incidence of gastric cancer has been observed in Western Europe and North America over the past 60 years and more recent declines in high-prevalence countries have also become apparent. This is epidemiologically distinct from the relative increase in tumours of the gastroesophageal junction, which are discussed in a separate guideline document.Risk factors for gastric cancer include male gender (incidence is twice as high), Helicobacter pylori infection, tobacco use, atrophic gastritis, partial gastrectomy and Ménétrier's disease [3]. Regional variation in gastric cancer risk factors influences the most common anatomical subsites of disease. Distal or antral gastric cancers that are associated with H. pylori infection, alcohol use, high-salt diet, processed meat and low fruit and vegetable intake are more common in East Asia. Tumours of the proximal stomach (cardia) are associated with obesity, and tumours of the gastroesophageal junction are associated with reflux and Barrett's oesophagus and are more common in non-Asian countries [4]. Gastric cancer demonstrates familial aggregation in∼ 10% of cases, and an inherited genetic predisposition is found in a small proportion of cases (∼ 1%–3%); relevant syndromes include hereditary non-polyposis colorectal cancer, familial adenomatous polyposis colorectal cancer, hereditary diffuse gastric cancer (HDGC), gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) and Peutz Jegher's syndrome [5, 6]. If a familial cancer syndrome such as HDGC is suspected, referral to a geneticist for assessment is recommended based on international clinical guidelines [V, B][7].